8-KEarnings & ResultsOther EventsExhibits & Filings

LAM RESEARCH CORP 8-K Report, Financial Results (Apr 22, 2020)

Filed April 22, 2020For Securities:LRCX

Summary

Lam Research Corporation (LRCX) filed an 8-K on April 22, 2020, primarily to announce its financial results for the fiscal quarter ended March 29, 2020. The filing also supplemented its risk factors, specifically addressing the adverse impact of the COVID-19 outbreak on its business, operations, and financial results. Investors should note that the information regarding financial results is furnished and not deemed "filed" for regulatory purposes. The company is acknowledging that the global pandemic and related containment measures have significantly disrupted its operations. This includes facility closures, production delays, supply chain disruptions, and challenges in staffing and business travel. These impacts are expected to lead to delays in shipments and product development, increased costs, and reduced revenue and profitability, with the potential for material adverse effects. The company also noted the broader economic uncertainty and potential impact on customer spending and ability to pay.

Key Highlights

  • 1Lam Research announced its financial results for the fiscal quarter ended March 29, 2020, via a press release filed as Exhibit 99.1.
  • 2The company is explicitly disclosing the adverse impacts of the COVID-19 outbreak on its business, operations, and financial results.
  • 3COVID-19 related disruptions include facility closures, production delays, supply chain interruptions, and staffing challenges.
  • 4These disruptions are expected to cause delays in product shipments and development, increase costs, and decrease revenue and profitability.
  • 5The company acknowledges the difficulty in predicting the duration and ultimate impact of the pandemic on its business and the global economy.
  • 6The filing also notes potential negative impacts on customer spending, ability to pay, and access to financing.
  • 7Information regarding financial results is furnished, not deemed 'filed' for Section 18 liability.

Frequently Asked Questions

This 8-K filing on April 22, 2020, primarily serves to announce Lam Research's financial results for the fiscal quarter ended March 29, 2020. The detailed financial figures are available in the press release attached as Exhibit 99.1.

The company explicitly states that the COVID-19 outbreak and related government measures have adversely impacted its business. This includes operational disruptions like facility closures, production delays, supply chain issues, and staffing challenges, which are expected to affect revenue, profitability, and product delivery.

Lam Research anticipates that the COVID-19 disruptions will lead to delays in product shipments and development, increased operational costs, and decreases in revenue and profitability. The company acknowledges that these effects may be material and the full extent of the impact is difficult to predict.

Yes, the 8-K supplements the company's existing risk factors by adding a specific disclosure detailing the adverse impact of the recent COVID-19 outbreak on its business, operations, and financial results. This should be read in conjunction with risk factors previously disclosed in their 10-K and 10-Q filings.